Stock Rich List
#237 on the corporate holders of 809 holders

Novo Holdings A/S

10% owner at Edgewise Therapeutics; 10% owner at Hemab Therapeutics Holdings; 10% owner at Avalyn Pharma.

$638M
in disclosed stock, +$2.7M (+0.43%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
237th of 809
Companies held
9
Largest holding
EWTX, 39.2% of total
Latest SEC filing
May 4, 2026

What the $638M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Edgewise Therapeutics EWTX
COMMON STOCK
Directly6,071,703$41.17$250M39.2%Form 4, Sep 14, 2022
Hemab Therapeutics Holdings COAG
Common Stock
Directly4,180,550$39.86$167M26.1%Form 4, May 4, 2026
Avalyn Pharma AVLN
Voting Common Stock
Directly3,883,289$28.70$111M17.5%Form 4, May 1, 2026
Disc Medicine IRON
Common Stock
Directly1,090,772$76.11$83.0M13.0%Form 4, Jun 28, 2023
MapLight Therapeutics MPLT
Voting Common Stock
Directly3,686,622$6.42$23.7M3.7%Form 4, Oct 28, 2025
Metagenomi Therapeutics MGX
COMMON STOCK
Directly1,739,175$0.61$1.1M0.2%Form 4, Feb 13, 2024
Bolt Biotherapeutics BOLT
COMMON STOCK
Directly185,200
split-adjusted
$5.06$937K0.1%Form 4, Jul 13, 2022
OnKure Therapeutics OKUR
Common Stock
Directly333,034
split-adjusted
$2.76$919K0.1%Form 4, Jun 23, 2023
Spruce Biosciences SPRB
COMMON STOCK
Directly453
split-adjusted
$40.49$18K0.0%Form 4, Mar 21, 2024

Share counts are the amounts Novo Holdings A/S reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
May 1, 2026BoughtAVLN555,555$18.00$10.0MView
Oct 28, 2025BoughtMPLT952,941$17.00$16.2MView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
234BCPE Derby (DE) SPV, LP
10% owner, Waystar Holding
$648M−$10.8M (−1.63%)
235Gilead Sciences, Inc.
10% owner, Arcus Biosciences
$641M+$470K (+0.07%)
236Corsair Group (Cayman), LP
10% owner, Corsair Gaming
$639M−$16.3M (−2.49%)
237Novo Holdings A/S
10% owner, Edgewise Therapeutics
$638M+$2.7M (+0.43%)
238WindAcre Partnership Master Fund, LP
10% owner, Perimeter Group
$633M−$3.2M (−0.51%)
239Public Investment Fund
Director, Lucid Group
$624M−$34.6M (−5.26%)
240Apollo Management IX, L.P.
10% owner, TD SYNNEX
$622M−$11.6M (−1.83%)

Other Edgewise Therapeutics insiders

All EWTX insiders

Questions

How much stock does Novo Holdings A/S own?

Novo Holdings A/S holds $637,688,044 in listed stock based on SEC filings and current prices, mostly Edgewise Therapeutics (EWTX). That ranks 237th on the Stock Rich List.

Is this Novo Holdings A/S's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Novo Holdings A/S last buy or sell stock?

The most recent open-market trade on file is a purchase of 555,555 AVLN shares on May 1, 2026 at $18.00.